These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 31418136)

  • 21. [Bacterial genome editing using the CRISPR/Cas12a system].
    Castagné P; Guingand A; Moderc A; Monard S
    Med Sci (Paris); 2018 May; 34(5):399-400. PubMed ID: 29900839
    [No Abstract]   [Full Text] [Related]  

  • 22. [The CRISPR/Cas system: a genome editing tool to develop animal models of viral infections].
    Castino G; Guillemet M; Joly A; Vignon A
    Med Sci (Paris); 2018 May; 34(5):403-405. PubMed ID: 29900841
    [No Abstract]   [Full Text] [Related]  

  • 23. Sequence-specific nucleases as tools for enhancing disease resistance in crops.
    Nekrasov V
    Transgenic Res; 2019 Aug; 28(Suppl 2):75-80. PubMed ID: 31321687
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Harnessing CRISPR to combat human viral infections.
    de Buhr H; Lebbink RJ
    Curr Opin Immunol; 2018 Oct; 54():123-129. PubMed ID: 30056335
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CRISPR-Cas Antiviral Strategies.
    Jin DY; Berkhout B
    Virus Res; 2018 Jan; 244():285. PubMed ID: 29406152
    [No Abstract]   [Full Text] [Related]  

  • 26. CRISPR-Cas9: From a bacterial immune system to genome-edited human cells in clinical trials.
    Kick L; Kirchner M; Schneider S
    Bioengineered; 2017 May; 8(3):280-286. PubMed ID: 28287876
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antiviral roles of plant ARGONAUTES.
    Carbonell A; Carrington JC
    Curr Opin Plant Biol; 2015 Oct; 27():111-7. PubMed ID: 26190744
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CRISPR/Cas9-Mediated Multiplex Genome Editing of the
    Sun Q; Lin L; Liu D; Wu D; Fang Y; Wu J; Wang Y
    Int J Mol Sci; 2018 Sep; 19(9):. PubMed ID: 30208656
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CRISPR/Cas13 as a Tool for RNA Interference.
    Ali Z; Mahas A; Mahfouz M
    Trends Plant Sci; 2018 May; 23(5):374-378. PubMed ID: 29605099
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CRISPR Applications in Plant Virology: Virus Resistance and Beyond.
    Kalinina NO; Khromov A; Love AJ; Taliansky ME
    Phytopathology; 2020 Jan; 110(1):18-28. PubMed ID: 31433273
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Targeted Gene Manipulation in Plants Using the CRISPR/Cas Technology.
    Zhang D; Li Z; Li JF
    J Genet Genomics; 2016 May; 43(5):251-62. PubMed ID: 27165865
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mimicking natural polymorphism in eIF4E by CRISPR-Cas9 base editing is associated with resistance to potyviruses.
    Bastet A; Zafirov D; Giovinazzo N; Guyon-Debast A; Nogué F; Robaglia C; Gallois JL
    Plant Biotechnol J; 2019 Sep; 17(9):1736-1750. PubMed ID: 30784179
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Crispr/Cas9 Mediated Inactivation of Argonaute 2 Reveals its Differential Involvement in Antiviral Responses.
    Ludman M; Burgyán J; Fátyol K
    Sci Rep; 2017 Apr; 7(1):1010. PubMed ID: 28432338
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CRISPR/Cas9-Based Genome Editing in Plants.
    Zhang Y; Ma X; Xie X; Liu YG
    Prog Mol Biol Transl Sci; 2017; 149():133-150. PubMed ID: 28712494
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CRISPR-Cas Technology in Viral Therapeutics.
    Woodland DL
    Viral Immunol; 2017 Oct; 30(8):547. PubMed ID: 28922076
    [No Abstract]   [Full Text] [Related]  

  • 36. Long-term evaluation of AAV-CRISPR genome editing for Duchenne muscular dystrophy.
    Nelson CE; Wu Y; Gemberling MP; Oliver ML; Waller MA; Bohning JD; Robinson-Hamm JN; Bulaklak K; Castellanos Rivera RM; Collier JH; Asokan A; Gersbach CA
    Nat Med; 2019 Mar; 25(3):427-432. PubMed ID: 30778238
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Response to Prins: broad virus resistance in transgenic plants.
    Uhrig JF
    Trends Biotechnol; 2003 Sep; 21(9):376-7. PubMed ID: 12948666
    [No Abstract]   [Full Text] [Related]  

  • 38. Application of the CRISPR/Cas System for Generation of Pathogen-Resistant Plants.
    Makarova SS; Khromov AV; Spechenkova NA; Taliansky ME; Kalinina NO
    Biochemistry (Mosc); 2018 Dec; 83(12):1552-1562. PubMed ID: 30878030
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficient DNA-free genome editing of bread wheat using CRISPR/Cas9 ribonucleoprotein complexes.
    Liang Z; Chen K; Li T; Zhang Y; Wang Y; Zhao Q; Liu J; Zhang H; Liu C; Ran Y; Gao C
    Nat Commun; 2017 Jan; 8():14261. PubMed ID: 28098143
    [TBL] [Abstract][Full Text] [Related]  

  • 40. History of CRISPR-Cas from Encounter with a Mysterious Repeated Sequence to Genome Editing Technology.
    Ishino Y; Krupovic M; Forterre P
    J Bacteriol; 2018 Apr; 200(7):. PubMed ID: 29358495
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.